https://api.elsevier.com/content/article/pii/S2352302621000600doi:10.1016/S2352-3026(21)00060-01-s2.0-S235230262100060010.1016/S2352-3026(21)00060-0S2352-3026(21)00060-0Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study The Lancet HaematologyJournal235230262021-05-31May 20210falsefalse